🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open, comparative, multi-centre study which will recr...
Status
Completed
Location
Institut Ste Catherine
Start Date
2017-10-18
Trial ID
NCT03249142
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested
This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-06-01
Trial ID
NCT03164616
This is an open label, randomized, Phase II multicenter study designed to e...
Status
Withdrawn
Location
Asklepios Fachkliniken München-Gauting
Start Date
2022-05-20
Trial ID
NCT05383001
Treatments Being Tested
The purpose of the study is to address the following hypotheses: (i) Anti-P...
Status
Completed
Location
Yale School of Medicine
Start Date
2015-11
Trial ID
NCT02489448
Treatments Being Tested
The purpose of this study is to test whether or not number of circulating c...
Status
Recruiting
Location
Stanford University
Start Date
2021-08-25
Trial ID
NCT04585490
Treatments Being Tested
The primary objective of this trial is to evaluate the synergistic effects ...
Status
Unknown
Location
National Cancer Center, Korea
Start Date
2019-07-04
Trial ID
NCT03899610
Treatments Being Tested
The standard or usual treatment for this disease consists of two chemothera...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2016-11-07
Trial ID
NCT02879318
Treatments Being Tested
First-line immunotherapy-based standard of care and local ablative treatmen...
Status
Recruiting
Location
Institut de Radiothérapie du Sud de l'Oise
Start Date
2025-09-09
Trial ID
NCT06840782
Treatments Being Tested